Miro E. Raeber

Zurich, ZH 8091, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

A systematic review of abatacept and belatacept in immune-mediated diseases.

A systematic review of abatacept and belatacept in immune-mediated diseases.

Journal: Journal of autoimmunity
Published: March 11, 2026

Dysregulation of homeostatic cytokine receptors drives prolonged T cell activation following acute SARS-CoV-2 infection in humans.

Dysregulation of homeostatic cytokine receptors drives prolonged T cell activation following acute SARS-CoV-2 infection in humans.

Journal: Nature communications
Published: May 05, 2025

Persistent complement dysregulation with signs of thromboinflammation in active Long Covid.

Persistent complement dysregulation with signs of thromboinflammation in active Long Covid.

Journal: Science (New York, N.Y.)
Published: January 18, 2024

Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics.

Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics.

Journal: Immunity
Published: December 27, 2023

Publisher Correction: Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2.

Publisher Correction: Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2.

Journal: Nature immunology
Published: August 21, 2023

Adaptive Immunosuppression in Lung Transplant Recipients Applying Complementary Biomarkers: The Zurich Protocol.

Adaptive Immunosuppression in Lung Transplant Recipients Applying Complementary Biomarkers: The Zurich Protocol.

Journal: Medicina (Kaunas, Lithuania)
Published: February 03, 2023

A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases.

A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases.

Journal: EBioMedicine
Published: December 16, 2022

Interleukin-2-based therapies in cancer.

Interleukin-2-based therapies in cancer.

Journal: Science translational medicine
Published: November 09, 2022

IL-2 immunotherapy rescues irradiation-induced T cell exhaustion in mouse colon cancer.

IL-2 immunotherapy rescues irradiation-induced T cell exhaustion in mouse colon cancer.

Journal: iScience
Published: November 08, 2022

Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2.

Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2.

Journal: Nature immunology
Published: October 07, 2022

Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures.

Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures.

Journal: Allergy
Published: February 10, 2022

T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19.

T-cell recovery and evidence of persistent immune activation 12 months after severe COVID-19.

Journal: Allergy
Published: January 17, 2022
Showing 1-12 of 25

Last Updated: 09/26/2026